Cardioprotection for Acute MI in Light of the CONDI2/ERIC-PPCI Trial: New Targets Needed
Protection against ischaemia–reperfusion injury after revascularisation in acute myocardial infarction remains an enigma. Many targets have been identified, but after the failure of the recent Effect of Remote Ischaemic Conditioning on Clinical Outcomes in ST-elevation Myocardial Infarction Patients...
Enregistré dans:
Auteurs principaux: | Joel P Giblett, Heerajnarain Bulluck |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Radcliffe Medical Media
2020
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/3741efb2e11b441eba1d4af3de1e62cf |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
ISCHEMIA Trial and the Significance of MI
par: Eduardo A Arias, et autres
Publié: (2020) -
What an Interventionalist Needs to Know About MI with Non-obstructive Coronary Arteries
par: Robert Sykes, et autres
Publié: (2021) -
Patent Foramen Ovale Closure in 2019
par: Joel P Giblett, et autres
Publié: (2019) -
Patent Foramen Ovale Closure: State of the Art
par: Joel P Giblett, et autres
Publié: (2020) -
Clinical profile of patients with qRBBB MI at tertiary care centre
par: Achal Sharma, et autres
Publié: (2021)